Karen Morrissey – COVID-19 Treatments: FDA Approved & Off Label Medications

*** Proof of Product ***

---

Exploring the Essential Features of “Karen Morrissey – COVID-19 Treatments: FDA Approved & Off Label Medications”

Speaker:Karen Morrissey, PhD, FNP, BC

Duration:1 Hour 59 Minutes

Format:Audio and Video

Copyright:Mar 25, 2022  

Media Type:Digital Seminar

Description

Karen Morrissey PhD, FNP, BC works as a telemedicine family nurse practitioner in a COVID-19 Initiative, delivering care to many patients experiencing COVID symptoms. As guidance continually evolves, this session will cover the latest effective treatment options regarding:

• Patient self-assessment
• Risk group priority tiers
• FDA approved treatments
• Off label treatments

Speaker

Karen Morrissey, PhD, FNP, BC, works as a telemedicine family nurse practitioner in a COVID-19 Initiative, delivering care to many patients experiencing COVID symptoms. She brings a wealth of experiences, drawing from roles in PACU, home care, pre-op and correctional nursing. Karen earned her FNP degree from the University of Connecticut and her PhD in Nursing from Walden University.

Speaker Disclosures:

Financial: Karen Morrissey has employment relationships with CVS Minute Clinic and Post University. She receives a speaking honorarium and recording royalties from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Karen Morrissey is a member of the American Association of Nurse Practitioners.

Objectives

1. Assess severity of symptoms to develop the most appropriate plan of care.
2. Evaluate current FDA approved COVID treatments for use in outpatient clinics.
3. Analyze non-FDA approved medications and understand why they are not yet approved.
4. Determine outpatient treatments that should be avoided.

Outline

As guidance continually evolves, learn from a real time discussion on the latest effective treatment options:

• Patient self-assessment 
• Symptom rating
• Risk group priority tiers
• FDA approved treatments by symptom
• Off label treatments
• Tixagevimab-Cigavimab Evusheld
• Monoclonal antibody therapy
• Casiriviman/imdevimab
• Sotrovimab
• Bamlaniviman-etesevimab
• Remdesivir veklury
• Nirmatrelvir-ritonavir Paxlovid
• Molnupiravir
• Outpatient therapies that should be avoided

Target Audience

• Nurses
• Nurse Practitioners
• Physicians
• Physicians Assistants

Please see the full list of alternative group-buy courses available here: https://lunacourse.com/shop/